Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

G-cell hyperplasia of the stomach induces ECL-cell proliferation in the pyloric glands in a paracrinal manner.

Pathology international·2015

Same author

[Latest pathological diagnosis that is important in thoracic surgery (2): epidermoid carcinoma of the lung].

Kyobu geka. The Japanese journal of thoracic surgery·2015

Same author

Pathology diagnosis of pancreatic neuroendocrine tumors.

Journal of hepato-biliary-pancreatic sciences·2015

Same author

Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissues.

The International journal of biological markers·2015

Same author

Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.

Cancer research·2015

Same author

Microvessel density in hepatocellular carcinoma: Prognostic significance and review of the previous published work.

Hepatology research : the official journal of the Japan Society of Hepatology·2015

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Aromatase in human lung carcinoma.

Mohit K Verma¹, Yasuhiro Miki, Hironobu Sasano

¹Department of Pathology, Tohoku University Graduate School of Medicine, 2-1 Seriyo-machi, Aoba-ku, Sendai 980-8575, Miyagi-ken, Japan.

|March 12, 2011

Summary

Gender differences in lung cancer are significant, especially in non-smokers. Estrogen synthesis via aromatase in lung tumors suggests aromatase inhibitors (AIs) could be a potential therapy for non-small cell lung cancer (NSCLC).

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Experiment Videos

Last Updated: Jun 3, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Area of Science:

Oncology
Endocrinology
Cancer Biology

Background:

Lung cancer exhibits gender disparities in clinical and biological aspects, with higher incidence in non-smoking females.
Estrogen synthesis occurs within lung tumors via aromatase, implicating sex steroids in lung carcinoma development.
Estrogen receptors are frequently expressed in human lung carcinomas, and lower aromatase expression correlates with better prognosis.

Purpose of the Study:

To investigate the role of intratumoral aromatase in the behavior of non-small cell lung cancer (NSCLC).
To explore the potential of aromatase inhibitors (AIs) as therapeutic options for NSCLC management.
To assess intratumoral aromatase expression as a predictive biomarker for clinical outcomes in NSCLC patients.

Main Methods:

Review of existing studies on gender differences in lung cancer.
Analysis of research on in situ estrogen synthesis and aromatase expression in lung tumors.
Evaluation of preclinical data on the effects of aromatase inhibitors (AIs) on lung tumor growth in vitro and in vivo.

Main Results:

Estrogen synthesis through aromatase is present in both male and female lung cancers.
Aromatase inhibitors (AIs) demonstrated suppression of lung tumor growth in preclinical models.
Lower aromatase expression is associated with improved prognosis in lung cancer patients.

Conclusions:

Intratumoral aromatase may play a significant role in the biological behavior of NSCLC.
Aromatase inhibitors (AIs) show promise as potential therapeutic agents for NSCLC.
Further research is needed to validate intratumoral aromatase as a predictive biomarker for NSCLC treatment outcomes.